Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery

Stopped early · Phase 4

Conditions studied: Corneal Transplantation

In brief

Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)

Key facts

Study ID

NCT00764582

Run by

Santen Inc.

People needed

60

Starts

2008-09-01

Last updated by the study team

2009-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Man or woman 18 years of age or older
• Scheduled for corneal transplant surgery
• Patients must be healthy enough to undergo surgery
• Women must be postmenopausal for at least 1 year or surgically sterile incapable of pregnancy
• Women must be abstinent at the discretion of the investigator
• Women practicing an effective method of birth control
• Women agree before entry to continue to use the same method of contraception throughout the study
• Women of childbearing potential must have a negative urine pregnancy test at screening

You may not qualify if…

• Presence of an active ocular infection or positive history of ocular herpetic infection
• History of severe dry eye syndrome
• Use of contact lenses in the 2 weeks prior to the study and for the duration of the study
• Received an experimental drug or used an experimental medical device within 30 days before the planned start of treatment
• Pregnant or breast feeding
• Employees of the investigator or study center with direct involvement in the proposed study or other studies under the direction of that investigator or study center as well as family members of the employees or the investigator

Where it is running

• Study site — Boynton Beach, Florida, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Great Rapids, Michigan, United States
• Study site — Kansas City, Missouri, United States
• Study site — Springfield, Missouri, United States
• Study site — Stony Brook, New York, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.